Parker Edman is Director of Market Access & Analytics at Magnolia Market Access. He has over 6 years of consulting experience, delivering enterprise-wide and product-specific strategies to pharmaceutical manufacturers, payers, and trade associations.
Parker is passionate about improving access to and affordability of drugs for patients. He has extensive experience using real-world data, which he often applies to inform pricing and reimbursement strategies for clients across a product’s life cycle. He also draws on his policy and economic modeling expertise to inform legislative and regulatory discussions on drug pricing and reimbursement reform.
Parker also has expertise in specialty products, end-of-life products, orphan and rare-disease treatments, and biosimilars.
Prior to joining Magnolia, Parker worked as an associate at Leavitt Partners, a management consulting firm that helps companies transition to value-based care.
Parker holds a Bachelor of Science in quantitative analysis of markets and organizations from the University of Utah.